Exozymes (EXOZ) Cash from Investing Activities (2023 - 2024)
Exozymes (EXOZ) has disclosed Cash from Investing Activities for 2 consecutive years, with -$210407.0 as the latest value for Q4 2024.
- Quarterly Cash from Investing Activities fell 91.73% to -$210407.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$359216.0 through Dec 2024, changed N/A year-over-year, with the annual reading at -$150218.0 for FY2025, 58.18% up from the prior year.
- Cash from Investing Activities for Q4 2024 was -$210407.0 at Exozymes, down from $30857.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $30857.0 in Q3 2024, with the low at -$210407.0 in Q4 2024.